PHARMACEUTICAL PREPARATIONS

Latest POS462C SEC Filings
Post-effective amendment to registration statement [Rule 462(c)]

AVANIR PHARMACEUTICALS, POS462C, 2000-10-18


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission